About Regeneron Pharmaceuticals

Regeneron Pharmaceuticals, Inc. is a renowned biotechnology company founded in 1988, known for its cutting-edge research and development efforts in the field of biopharmaceuticals. Regeneron specializes in the discovery, development, and commercialization of innovative medicines for various diseases, including eye diseases, cancer, and rare genetic disorders. The company is particularly recognized for its work in developing monoclonal antibody therapies and its significant contributions to the healthcare industry, including the development of treatments for age-related macular degeneration and COVID-19. Regeneron's role in advancing scientific research and providing groundbreaking treatments establishes it as a significant player in the biotechnology and pharmaceutical sectors, contributing to advancements in healthcare and patient well-being.